Hypoxia contributes to the generation of immunosuppressive TME and immunotherapeutic resistance by upregulating HIF-1α signaling pathways and triggering the expression of VEGF, PDGF, and other cytokines, resulting in a modification of tumor metabolism, angiogenesis, and lymphangiogenesis (76) (Figure 1). This evidence concerns the gene VEGFA and neoplasm.